Overview of Ribonucleotide Reductase Inhibitors: An Appealing Target in Anti-Tumour Therapy

By  

Current Medicinal Chemistry, Vol. 12, Iss. 11, 2005-06 ,pp. : 1283-1294

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting ribonucleotide reductase for cancer therapy

By Shao Jimin   Liu Xiyong   Zhu Lijun   Yen Yun  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. : 1423-1437

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapeutic targets in antiviral and anticancer therapy: a role for ribonucleotide reductase

By Novotny L.   Fritzer-Szekeres M.   Szekeres T.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 2, 1999-06 ,pp. : 251-261

Informa Healthcare

Access to resources Recommend Favorite

Ribonucleotide Reductase as One Important Target of [Tris(1,10- phenanthroline)lanthanum(III)] Trithiocyanate (KP772)

By  

Current Cancer Drug Targets, Vol. 9, Iss. 5, 2009-08 ,pp. : 595-607

Bentham Science Publishers

Access to resources Recommend Favorite

Methylenetetrahydrofolate Reductase (MTHFR): A Novel Target for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1143-1150

Bentham Science Publishers

Access to resources Recommend Favorite